Key Dates

Related Announcements

RFA-DA-23-046 - HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice is to inform potential applicants that the Division of Epidemiology, Services, and Prevention Research (DESPR) at the National Institute on Drug Abuse (NIDA) will host a pre-application webinar on Wednesday, September 28, 2022, from 3:30 p.m. to 5:30 p.m. (Eastern Daylight Time, EDT) for those interested in learning more about RFA-DA-23-046 - HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional). Staff from NIDA and the other institutes participating in the RFA (The National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Center for Complementary and Integrative Health NCCIH) will review RFA-DA-23-046 and answer questions from prospective applicants. Details on how to attend and submit questions will soon be available on the NIDA Meetings and Events page

Participation in the webinar is not required to submit an application. We plan to post a recording of the on the NIDA Meetings and Events page after the meeting.

Inquiries

Please direct all inquiries to:

Sarah Q. Duffy, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-451-4998
Email: [email protected]